Jack Stewart discusses SOR-C18 leading the phase 1b clinical trial in pancreatic cancer
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13 is the leading drug in a phase 1b clinical trial in late stage pancreatic cancer.
Author: Cancer-News
Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2019 Category: Cancer & Oncology Source Type: podcasts
Jack Stewart discusses SOR-C18 disruption of TRPV6
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13, a selective inhibitor of TRPV6, binds with affinity and disrupts how TRPV6 functions.
Author: Cancer-News
Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2019 Category: Cancer & Oncology Source Type: podcasts
Jack Stewart discusses SOR-C18 potential in different cancers
Jack Stewart, CSO of Soricimed Biopharma elaborates on how SOR-C18 potentially showing promise in ovarian, metastatic prostate and pancreatic cancer.
Author: Cancer-News
Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2019 Category: Cancer & Oncology Source Type: podcasts
Pascal Besman discusses lurbinectedin accelerated approval with FDA
PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Pascal Besman, Pharmamar COO discusses advantages and potential limitations of the new d...
Author: PharmaMar
Added: 08/22/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Prostate and Kidney Cancer Studies Awaiting Determinnation from FDA
Sarmad Sadeghi, MD, PhD, discusses studies that are awaiting determinations fom the FDA.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
The Need for Nephrectomy
Sarmad Sadeghi, MD, PhD, discusses moving away from the need for Nephrectomy.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Enzamet - Plenary Session / TITAN
Sarmad Sadeghi, MD, PhD, discuses the Enzalutamide and Apalutamide studies.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Alternate Dosing For Immunotherapy
John Freuhauf, M.D., PhD, discusse Lowering Toxicity through alternate dosing.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Will The CheckMate 204 Study Impact Clinicians Today?
John Feuhauf discusses findings of the CheckMate 204 study.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
CheckMate 204 Study
New first line therapy for Asymptomatic Melanoma Brain Metastases.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Could Clinicians Change The Way They Treat Patients
John Freuhauf, M.D., PhD, discusses toxic therapy and how it could change.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Fixing Toxic Therapy
Addressing toxity that causes colitis.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Is INMC Data Practice Changing
John Freuhauf, M.D., PhD, discusses practice changing data from INMC.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
How Data form INMC Has Impacted Surgical Oncologists
Johan Freufauf, M.D., PhD, discusses findings form the INMC.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
International Neoadjuvant Melanoma Consortium
John Fruehauf, M.D., PhD,discusses the International Neoadjuvant Melanoma Consortuim.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts